GPX1 (Glutathione Peroxidase 1) is one of the most critical antioxidant enzymes in mammalian cells and plays a central role in protecting neurons from oxidative damage. As a selenoprotein, GPX1 requires selenium for its activity and catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to water and corresponding alcohols, using glutathione (GSH) as the electron donor.
GPX1 is among the most studied antioxidant enzymes in neurodegenerative disease research due to its central role in mitigating oxidative stress, a hallmark of Alzheimer's disease, Parkinson's disease, and related disorders.
| Symbol |
GPX1 |
| Full Name |
Glutathione Peroxidase 1 |
| Chromosome |
3p21.31 |
| NCBI Gene |
2783 |
| Ensembl |
ENSG00000133247 |
| OMIM |
138320 |
| UniProt |
P07203 |
| Protein Type |
Selenoprotein, Antioxidant enzyme |
| Molecular Weight |
22.5 kDa |
| Subcellular Location |
Cytosol, Mitochondria |
| Cofactor |
Selenium (selenocysteine) |
GPX1 (Glutathione Peroxidase 1) is a gene located on chromosome 3p21.31 that encodes a selenoprotein enzyme crucial for cellular antioxidant defense. GPX1 catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and corresponding alcohols, using glutathione as the electron donor.
GPX1 is one of the most abundant selenoproteins in mammals and plays a central role in protecting cells from oxidative damage. The enzyme operates in the cytosol and mitochondria, providing broad antioxidant protection throughout the cell.
¶ Gene Structure and Regulation
- Location: 3p21.31 (chr3: 49,310,500-49,315,700, GRCh38)
- Gene length: ~5.2 kb
- Exons: 2 coding exons
- mRNA length: 654 bp (NM_000581)
- Protein length: 203 amino acids
GPX1 contains a selenocysteine (Sec) residue at position 46 (UGA codon), which is essential for catalytic activity. This requires:
- SECIS element: Hairpin structure in 3' UTR for Sec insertion
- tRNASec: Specialized tRNA carrying selenocysteine
- EFSec: Elongation factor for selenoprotein translation
GPX1 expression is regulated by multiple factors:
| Factor |
Effect |
Mechanism |
| Nrf2 |
Activation |
Antioxidant response elements (ARE) |
| p53 |
Activation |
Direct binding to promoter |
| NF-κB |
Repression |
Transcriptional inhibition |
| Selenium availability |
Activation |
Translation regulation |
| Oxidative stress |
Activation |
ARE-mediated transcription |
¶ Protein Structure and Function
GPX1 catalyzes the following reaction:
2 GSH + ROOH → GSSG + H₂O + ROH
Where:
- GSH = reduced glutathione
- GSSG = oxidized glutathione
- ROOH = organic hydroperoxide
Catalytic cycle:
- Sec residue attacks peroxide substrate
- Selenenyl-sulfide intermediate forms
- Two GSH molecules reduce the intermediate
- GSSG formed, enzyme regenerated
- N-terminal region: Dimerization interface
- Catalytic center: Selenocysteine at position 46
- GSH binding site: C-terminal region
- Substrate access channel: Central cavity
GPX1 localizes to:
- Cytosol: ~70% of total cellular GPX1
- Mitochondria: ~30% (targeted by alternative translation start)
- Nucleus: Small fraction (stress-induced)
| Tissue |
Expression |
Notes |
| Liver |
Very high |
Primary expression site |
| Kidney |
High |
High basal expression |
| Heart |
High |
Cardiac protection |
| Brain |
Moderate |
Neurons and glia |
| Erythrocytes |
High |
Circulating antioxidant |
| Lung |
Moderate |
Barrier protection |
| Skeletal muscle |
Moderate |
Exercise-responsive |
In the central nervous system:
- Neurons: High expression in pyramidal neurons, Purkinje cells
- Astrocytes: Moderate expression
- Microglia: Lower expression, increases with activation
- Oligodendrocytes: Moderate expression
Region-specific:
- Hippocampus: High
- Cerebral cortex: High
- Cerebellum: Moderate
- Substantia nigra: High (dopaminergic neurons)
GPX1 is the primary enzyme for:
-
Hydrogen peroxide detoxification:
- Catalase-independent H₂O₂ removal
- Prevents hydroxyl radical formation
-
Lipid peroxidation prevention:
- Reduces lipid hydroperoxides
- Prevents ferroptosis
- Protects membrane integrity
-
DNA protection:
- Prevents oxidative DNA damage
- Maintains genomic integrity
-
Protein protection:
- Prevents oxidative protein damage
- Maintains enzyme function
GPX1 is integral to cellular stress response:
ROS (H₂O₂) → GPX1 activation → Signal transduction
↓
Antioxidant gene activation (via Nrf2)
↓
Cellular adaptation to stress
GPX1 protects mitochondria from oxidative damage:
- Complex I protection: Prevents oxidative damage to respiratory chain
- mtDNA protection: Maintains mitochondrial genome integrity
- Apoptosis regulation: Modulates intrinsic apoptotic pathway
- Mitophagy: Regulates mitochondrial quality control
GPX1 is significantly implicated in PD pathogenesis:
Pathological findings:
- GPX1 activity reduced by 40-60% in substantia nigra of PD patients
- GPX1 protein levels decreased in dopaminergic neurons
- Selenium levels reduced in PD brain
Mechanistic links:
- alpha-synuclein toxicity: GPX1 protects against oxidative stress induced by alpha-synuclein aggregation
- Mitochondrial dysfunction: GPX1 deficiency exacerbates complex I damage
- Dopaminergic neuron vulnerability: High oxidative stress makes neurons particularly dependent on GPX1
Genetic association:
- GPX1 Pro198Leu variant associated with PD risk in some populations
- GPX1 promoter polymorphisms affect expression
GPX1 involvement in AD:
Pathological changes:
- GPX1 activity reduced in AD hippocampus and cortex
- Inverse correlation with amyloid burden
- Correlation with cognitive decline
Mechanistic connections:
- Amyloid-beta toxicity: GPX1 protects against Aβ-induced oxidative stress
- Tau pathology: GPX1 reduction exacerbates tau hyperphosphorylation
- Neuroinflammation: GPX1 modulates microglial oxidative stress
ALS connections:
- Reduced GPX1 activity in motor neurons
- GPX1 overexpression delays disease onset in SOD1 mice
- Selenium deficiency accelerates disease progression
- Interaction with other antioxidant systems (SOD1, catalase)
¶ Stroke and Ischemia
Ischemic injury:
- GPX1 provides neuroprotection against cerebral ischemia
- GPX1 knockout mice show larger infarcts
- Preconditioning induces GPX1 expression
Reperfusion injury:
- GPX1 critical for managing oxidative burst
- Overexpression protects against hemorrhagic transformation
| Condition |
GPX1 Status |
Notes |
| Huntington's disease |
Reduced |
In striatum |
| Multiple sclerosis |
Variable |
Active lesions reduced |
| Frontotemporal dementia |
Reduced |
Temporal cortex |
| Prion disease |
Reduced |
Prion-infected brain |
Selenium increases GPX1 expression and activity:
- Dietary selenium: Required for GPX1 synthesis
- Selenomethionine: Organic selenium, better absorption
- Selenite: Inorganic form, also effective
Clinical considerations:
- Optimal dose: 50-200 μg/day
- Monitoring: GPX1 activity as biomarker
- Toxicity: Upper limit ~400 μg/day
| Strategy |
Compound |
Stage |
| GPX1 expression |
Ebselen (selenium donor) |
Clinical |
| GPX1 activity |
Synthetic selenocompounds |
Preclinical |
| Gene therapy |
AAV-GPX1 |
Preclinical |
| Small molecule |
N-acetylcysteine (GSH precursor) |
Clinical |
- Exercise: Increases GPX1 activity in brain
- Caloric restriction: Upregulates GPX1 expression
- Mediterranean diet: High selenium sources
- Antioxidant supplements: Combined approach
| Protein |
Interaction |
Function |
| SOD1 |
Complementary |
Primary antioxidant enzymes |
| Catalase |
Complementary |
H₂O₂ detoxification |
| Thioredoxin |
Regeneration |
Maintains reduced state |
| Glutathione reductase |
Regeneration |
Maintains GSH pool |
| Nrf2 |
Regulation |
Transcriptional activation |
- alpha-synuclein: GPX1 protects against oxidative modifications
- Amyloid-beta: GPX1 reduces Aβ-induced ROS
- Tau: GPX1 mitigates oxidative stress in tauopathy
- SOD1: Cooperates in ALS models
- What is the precise contribution of GPX1 vs. other GPX family members?
- Can selective GPX1 activation provide therapeutic benefit?
- What determines neuronal vulnerability to GPX1 deficiency?
- How does GPX1 interact with ferroptosis pathways?
- GPX1 and ferroptosis: New links to iron-dependent cell death
- Single-cell analysis: Cell-type specific GPX1 function
- Optogenetics: Light-controlled GPX1 activity
¶ GPX1 and the Selenocysteine Code
The "selenocysteine code" refers to the specialized machinery required to incorporate the 21st amino acid, selenocysteine (Sec), into proteins. GPX1 exemplifies this complexity:
Sec vs. Cysteine:
Incorporation machinery:
- SECIS binding protein 2 (SBP2): Binds SECIS element in mRNA
- Sec-specific tRNA (tRNASec): Carries Sec to ribosome
- Elongation factor (EFSec): Delivers Sec-tRNA to ribosome
- SECIS element: Stem-loop structure in 3' UTR
Regulation by selenium:
- Selenium availability directly affects GPX1 translation
- Low selenium reduces GPX1 without affecting other selenoproteins
- Different selenoproteins have different selenium thresholds
Cellular senescence is characterized by irreversible cell cycle arrest and secretory phenotype (SASP). GPX1 plays a role in senescence:
Senescence-associated changes:
- GPX1 activity decreases in senescent cells
- This contributes to ROS accumulation and SASP
- Overexpression of GPX1 delays senescence onset
Therapeutic implications:
- GPX1 modulators could influence aging
- Senolytic strategies might target GPX1-low cells
- Antioxidant interventions could modify SASP
GPX1 affects neural stem cell function:
- GPX1 is expressed in neural progenitor cells
- Supports proliferation through ROS management
- Differentiation requires GPX1 modulation
- Overexpression enhances neurogenesis in models
¶ GPX1 and Blood-Brain Barrier
GPX1 protects the blood-brain barrier (BBB):
- Endothelial GPX1 maintains BBB integrity
- Oxidative stress disrupts BBB; GPX1 prevents this
- GPX1 deficiency increases BBB permeability
- Therapeutic potential for stroke and MS
¶ GPX1 Polymorphisms and Disease Risk
Several GPX1 polymorphisms have been studied:
| Polymorphism |
Effect |
Disease Association |
| Pro198Leu |
Reduced activity |
PD risk (some populations) |
| -602A>G |
Altered expression |
AD risk |
| Codon 5 variants |
Variable |
Cardiovascular disease |
| 3' UTR variants |
mRNA stability |
Cancer risk |
Several methods exist to assess GPX1:
- Enzyme assay: Measure NADPH consumption during catalysis
- Western blot: Protein level quantification
- mRNA expression: qPCR for transcript levels
- Selenium status: Correlates with GPX1 activity
- Activity-based probes: Chemical tools for active GPX1
Clinical and research applications:
- Biomarker for oxidative stress
- Response to selenium supplementation
- Disease progression marker
- Therapeutic efficacy marker